Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ORKA Oruka Therapeutics Inc.
- Stocks
- Healthcare
- NASDAQ: ORKA
Price (delayed)
$9.54
Market cap
$357.18M
P/E Ratio
N/A
Dividend/share
$19.36
EPS
-$3.87
Enterprise value
$296.58M
Highlights
Oruka Therapeutics's EPS has increased by 38% from the previous quarter and by 13% YoY
The company's equity rose by 12% QoQ
The company's quick ratio has shrunk by 51% YoY but it rose by 26% QoQ
Oruka Therapeutics's net income has shrunk by 143% QoQ
Key stats
What are the main financial stats of ORKA
Market
Valuations
Earnings
Shares outstanding
37.44M
Market cap
$357.18M
Enterprise value
$296.58M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.87
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$88.12M
Net income
-$83.72M
EBIT
-$82.26M
EBITDA
-$82.1M
Free cash flow
-$58.03M
Per share
Balance sheet
Liquidity
EPS
-$3.87
EPS diluted
-$3.87
Free cash flow per share
-$3.46
Book value per share
$10.92
Revenue per share
$0
TBVPS
$23.59
Total assets
$396.02M
Total liabilities
$13.8M
Debt
$968,000
Equity
$382.22M
Working capital
$363.83M
Debt to equity
0
Current ratio
28.89
Quick ratio
28.8
Net debt/EBITDA
0.74
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-38.6%
Return on equity
-39.9%
Return on invested capital
-51%
Return on capital employed
-21.5%
Return on sales
N/A
Dividend yield
202.9%
DPS
$19.36
Payout ratio
N/A
ORKA stock price
How has the Oruka Therapeutics stock price performed over time
Intraday
2.69%
1 week
-8.62%
1 month
25.2%
1 year
-75.84%
YTD
-50.8%
QTD
-7.02%
Financial performance
How have Oruka Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$88.12M
Net income
-$83.72M
Gross margin
N/A
Net margin
N/A
Oruka Therapeutics's net income has shrunk by 143% QoQ
ORKA's operating income has dropped by 140% since the previous quarter
Price vs fundamentals
How does ORKA's price correlate with its fundamentals
Growth
What is Oruka Therapeutics's growth rate over time
Valuation
What is Oruka Therapeutics stock price valuation
P/E
N/A
P/B
0.87
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Oruka Therapeutics's EPS has increased by 38% from the previous quarter and by 13% YoY
ORKA's price to book (P/B) is 100% lower than its last 4 quarters average of 5765.1 and 100% lower than its 5-year quarterly average of 1214.3
The company's equity rose by 12% QoQ
Efficiency
How efficient is Oruka Therapeutics business performance
Oruka Therapeutics's return on assets has shrunk by 190% YoY and by 154% QoQ
The return on equity has dropped by 189% year-on-year and by 120% since the previous quarter
Dividends
What is ORKA's dividend history
DPS
$19.36
Dividend yield
202.9%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Oruka Therapeutics financials performed over time
The company's current ratio has shrunk by 51% YoY but it rose by 26% QoQ
The company's quick ratio has shrunk by 51% YoY but it rose by 26% QoQ
The company's debt is 100% lower than its equity
The company's debt to equity has shrunk by 100% YoY
The company's equity rose by 12% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.